These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5424003)

  • 1. Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
    Chase TN; Schnur JA; Gordon EK
    Neuropharmacology; 1970 May; 9(3):265-8. PubMed ID: 5424003
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
    Messiha FS
    J Neurol Sci; 1974 Jan; 21(1):39-46. PubMed ID: 4216622
    [No Abstract]   [Full Text] [Related]  

  • 3. Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism.
    Gottfries CG; Gottfries I; Roos BE
    J Neurochem; 1969 Sep; 16(9):1341-5. PubMed ID: 5808100
    [No Abstract]   [Full Text] [Related]  

  • 4. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
    Pind K; Faurbye A
    Acta Psychiatr Scand; 1970; 46(4):323-6. PubMed ID: 4323062
    [No Abstract]   [Full Text] [Related]  

  • 6. Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of Guam.
    Brody JA; Chase TN; Gordon EK
    N Engl J Med; 1970 Apr; 282(17):947-50. PubMed ID: 5436031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 8. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
    Rinne UK; Sonninen V
    Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
    Chase TN
    Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
    [No Abstract]   [Full Text] [Related]  

  • 11. Acid metabolites from monoamines in cerebrospinal fluid of chronic schizophrenics.
    Persson T; Roos BE
    Br J Psychiatry; 1969 Jan; 115(518):95-8. PubMed ID: 5781964
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of monoamine metabolites in human cerebrospinal fluid to age.
    Bowers MB; Gerbode FA
    Nature; 1968 Sep; 219(5160):1256-7. PubMed ID: 5677419
    [No Abstract]   [Full Text] [Related]  

  • 13. Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid.
    Curzon G; Gumpert EJ; Sharpe DM
    Nat New Biol; 1971 Jun; 231(23):189-91. PubMed ID: 5281200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 15. The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia.
    Rimón R; Roos BE; Räkköläinen V; Alanen Y
    J Psychosom Res; 1971 Sep; 15(3):375-8. PubMed ID: 5564448
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of L-Dopa in drug induced extrapyramidalism.
    Yaryura-Tobias JA; Wolpert A; Dana L; Merlis S
    Dis Nerv Syst; 1970 Jan; 31(1):60-3. PubMed ID: 5413729
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease. Modification by 5-hydroxytryptophan.
    Chase TN; Ng LK; Watanabe AM
    Neurology; 1972 May; 22(5):479-84. PubMed ID: 4563493
    [No Abstract]   [Full Text] [Related]  

  • 18. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 19. [Values of serial determinations of cerebrospinal fluid metabolites of biogenic amines in various neurologic diseases].
    Spissu A; Piccardi MP; Corsini GU; Mangoni A
    Acta Neurol (Napoli); 1976; 31(5):549-57. PubMed ID: 827925
    [No Abstract]   [Full Text] [Related]  

  • 20. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex.
    Gottfries CG; Gottfries I; Johansson B; Olsson R; Persson T; Roos BE; Sjöström R
    Neuropharmacology; 1971 Nov; 10(6):665-72. PubMed ID: 5128025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.